Skip to main content
Year archive

OliX Pharmaceuticals, Inc. — 2018 filings

All 16 regulatory filings released by OliX Pharmaceuticals, Inc. (226950) in 2018, sourced directly from the official regulator.

16 Filings
2018 Period
2018 filings (16)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2018-12-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2018-11-14 Korean
기업설명회(IR)개최
Regulatory Filings
2018-11-13 Korean
기타경영사항(특허권취득)(자율공시)(RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR)
Regulatory Filings
2018-11-13 Korean
분기보고서 (2018.09)
Interim / Quarterly Report 9M 2018
2018-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2018-11-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2018-11-12 Korean
기타경영사항(자율공시)(신주인수권 발행결과)
Share Issue/Capital Change
2018-11-06 Korean
기타경영사항(특허권취득)(자율공시)(작은 간섭 RNA의 RNA 간섭효과 증진용 화합물 및 이의 용도)
Regulatory Filings
2018-11-02 Korean
기업설명회(IR)개최
Regulatory Filings FY 2018
2018-10-30 Korean
기타경영사항(자율공시)(신주인수권 행사)
Share Issue/Capital Change
2018-10-22 Korean
타법인주식및출자증권취득결정
Capital/Financing Update
2018-10-22 Korean
기업설명회(IR)개최
Investor Presentation
2018-10-17 Korean
기업설명회(IR)개최
Regulatory Filings Q4 2018
2018-10-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2018-10-16 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2018-10-12 Korean